Obesity control may be by several mechanisms, one of which being that orlistat prevents fat hydrolysis by acting as a gastric and pancreatic lipase inhibitor (Heck, Yanovski & Calis, 2012; Yanovski & Yanovski, 2014). This evidence concerns the gene PNLIP and obesity due to melanocortin 4 receptor deficiency.